Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bandaram Pharma Packtech Ltd announced board-level changes effective January 30, 2026. Mr. Eswar Reddy Putturu has been appointed as an Additional Director in the Non-Executive Independent category for a 5-year term, subject to shareholder approval. He holds an MBA in Finance and Marketing and brings experience in banking product marketing and financial analysis. Separately, Mrs. Priyanka Agarwal has resigned from her position as Non-Executive Independent Director citing personal reasons, and confirmed there are no other material reasons for her exit. The incoming director holds no shares in the company, and is not debarred by SEBI from holding directorship.
This is a routine board-level reshuffle with one Independent Director exiting and another replacing them — net board composition remains unchanged. No governance red flags are evident, and the changes are unlikely to materially affect the stock price or shareholder interests.